Intervention not reported
Lung function: FEV1 (L) · patients with COPD
1 finding from 1 review
FEV1 · adults and children with acute exacerbation of asthma
1 finding from 1 review
PEF (L/min) · adults and children with acute exacerbation of asthma
2 findings from 1 review
Admission to hospital at initial presentation · adults and children with acute exacerbation of asthma
MgSO4 + SABA showed no clear difference in admission to hospital at initial presentation compared with SABA (low certainty).
1 finding from 1 review
Serious adverse events (During ED/hospital admission) · adults and children with acute exacerbation of asthma
1 finding from 1 review
Any adverse events (During ED/hospital admission) · adults and children with acute exacerbation of asthma
1 finding from 1 review
Lung function · adults and children with acute exacerbation of asthma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical severity score ‐ Fischl index (120 minutes) · adults and children with acute exacerbation of asthma
1 finding from 1 review
Admission to hospital at initial presentation · adults and children with acute exacerbation of asthma
It is very uncertain whether mgSO4 changes admission to hospital at initial presentation compared with SABA (very low certainty).
1 finding from 1 review
Serious adverse events (During ED/hospital admission) · adults and children with acute exacerbation of asthma
1 finding from 1 review
Pulmonary function % predicted PEF (60 minutes) · adults and children with acute exacerbation of asthma
1 finding from 1 review
Clinical severity scores (60 minutes) · adults and children with acute exacerbation of asthma
1 finding from 1 review
Admission to hospital at initial presentation · adults and children with acute exacerbation of asthma
MgSO4 + SABA + ipratropium showed no clear difference in admission at first presentation compared with SABA + ipratropium (moderate certainty).
1 finding from 1 review
Patient readmissions · adults and children with acute exacerbation of asthma
MgSO4 + SABA + ipratropium showed no clear difference in readmission (7 to 30 days) compared with SABA + ipratropium (low certainty).
1 finding from 1 review
Serious adverse events (during admission) · adults and children with acute exacerbation of asthma
1 finding from 1 review
Adverse effects Defined as any adverse event occurring post‐admission · adults and children with acute exacerbation of asthma
1 finding from 1 review
FEV1 % predicted · adults and children with acute exacerbation of asthma
1 finding from 1 review
All‐cause mortality · Patients admitted to hospital with acute hypercapnic respiratory failure due to an exacerbation of chronic obstructive pulmonary disease…
Non‐invasive ventilation probably leads to lower mortality compared with usual medical care (moderate certainty).
1 finding from 1 review
Need for intubation · Patients admitted to hospital with acute hypercapnic respiratory failure due to an exacerbation of chronic obstructive pulmonary disease…
Non‐invasive ventilation probably leads to lower need for endotracheal intubation compared with usual medical care (moderate certainty).
1 finding from 1 review
Length of hospital stay · Patients admitted to hospital with acute hypercapnic respiratory failure due to an exacerbation of chronic obstructive pulmonary disease…
1 finding from 1 review